» Articles » PMID: 20403936

Tolerance and Withdrawal from Prolonged Opioid Use in Critically Ill Children

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2010 Apr 21
PMID 20403936
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: After prolonged opioid exposure, children develop opioid-induced hyperalgesia, tolerance, and withdrawal. Strategies for prevention and management should be based on the mechanisms of opioid tolerance and withdrawal.

Patients And Methods: Relevant manuscripts published in the English language were searched in Medline by using search terms "opioid," "opiate," "sedation," "analgesia," "child," "infant-newborn," "tolerance," "dependency," "withdrawal," "analgesic," "receptor," and "individual opioid drugs." Clinical and preclinical studies were reviewed for data synthesis.

Results: Mechanisms of opioid-induced hyperalgesia and tolerance suggest important drug- and patient-related risk factors that lead to tolerance and withdrawal. Opioid tolerance occurs earlier in the younger age groups, develops commonly during critical illness, and results more frequently from prolonged intravenous infusions of short-acting opioids. Treatment options include slowly tapering opioid doses, switching to longer-acting opioids, or specifically treating the symptoms of opioid withdrawal. Novel therapies may also include blocking the mechanisms of opioid tolerance, which would enhance the safety and effectiveness of opioid analgesia.

Conclusions: Opioid tolerance and withdrawal occur frequently in critically ill children. Novel insights into opioid receptor physiology and cellular biochemical changes will inform scientific approaches for the use of opioid analgesia and the prevention of opioid tolerance and withdrawal.

Citing Articles

Sedative and Analgesic Drug Rotation Protocol Versus Non-Rotation Protocol in Mechanically Ventilated Children: A Randomised Controlled Trial.

Pradeep Babu U, Toteja N, Choudhary B, Singh K, Didel S, Khera D Indian J Pediatr. 2025; .

PMID: 40042783 DOI: 10.1007/s12098-025-05447-4.


Estimated equipotent conversion ratios of morphine, sufentanil and fentanyl as continuous infusion in neonatal intensive care units: a pharmacoepidemiologic cohort study.

Tauzin M, Cavalier I, Ortala M, Jung C, Gouyon B, Durrmeyer X Eur J Clin Pharmacol. 2024; 81(3):375-381.

PMID: 39729106 DOI: 10.1007/s00228-024-03796-1.


Massage Therapy Utilization in Pediatric Acute Burns: A Retrospective Cohort Study.

Reader B, Zerkle D, Fabia R, Thakkar R, Schwartz D Int J Ther Massage Bodywork. 2024; 17(4):20-26.

PMID: 39669543 PMC: 11623310. DOI: 10.3822/ijtmb.v17i4.1043.


A deep learning model for estimating sedation levels using heart rate variability and vital signs: a retrospective cross-sectional study at a center in South Korea.

Kim Y, Lee B, Jang W, Jeon Y, Park J Acute Crit Care. 2024; 39(4):621-629.

PMID: 39600246 PMC: 11617840. DOI: 10.4266/acc.2024.01200.


Opioid equipotency conversions for hospitalized infants: a systematic review.

Ing M, Keane O, Lakshmanan A, Kim E, Lee H, Kelley-Quon L J Perinatol. 2024; 44(12):1709-1718.

PMID: 39304731 PMC: 11606914. DOI: 10.1038/s41372-024-02121-z.


References
1.
Levine J, Gordon N, Taiwo Y, Coderre T . Potentiation of pentazocine analgesia by low-dose naloxone. J Clin Invest. 1988; 82(5):1574-7. PMC: 442725. DOI: 10.1172/JCI113768. View

2.
Crain S, Shen K . Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci. 1998; 19(9):358-65. DOI: 10.1016/s0165-6147(98)01241-3. View

3.
Unal C, Owen M, Millington W . Cyclo(Gly-Gln) inhibits the cardiorespiratory depression produced by beta-endorphin and morphine. Brain Res. 1997; 747(1):52-9. DOI: 10.1016/s0006-8993(96)01261-9. View

4.
Kosten T, Rounsaville B, KLEBER H . Comparison of clinician ratings to self reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse. 1985; 11(1-2):1-10. DOI: 10.3109/00952998509016845. View

5.
Mitchell J, Basbaum A, Fields H . A locus and mechanism of action for associative morphine tolerance. Nat Neurosci. 1999; 3(1):47-53. PMC: 4327857. DOI: 10.1038/71120. View